Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Associations between prediagnostic aspirin use and ovarian tumor gene expression

Title: Associations between prediagnostic aspirin use and ovarian tumor gene expression
Authors: Naoko Sasamoto; Paul A. Stewart; Tianyi Wang; Zachary J. Thompson; Sean J. Yoder; Jonathan L. Hecht; John L. Cleveland; Jose Conejo‐Garcia; Brooke L. Fridley; Kathryn L. Terry; Shelley S. Tworoger
Source: Cancer Medicine, Vol 12, Iss 17, Pp 18405-18417 (2023)
Publisher Information: Wiley
Publication Year: 2023
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: aspirin; gene expression; interferon gamma; ovarian cancer; tumor microenvironment; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
Description: Background Aspirin use has been associated with reduced ovarian cancer risk, yet the underlying biological mechanisms are not fully understood. To gain mechanistic insights, we assessed the association between prediagnosis low and regular‐dose aspirin use and gene expression profiles in ovarian tumors. Methods RNA sequencing was performed on high‐grade serous, poorly differentiated, and high‐grade endometrioid ovarian cancer tumors from the Nurses' Health Study (NHS), NHSII, and New England Case–Control Study (n = 92 cases for low, 153 cases for regular‐dose aspirin). Linear regression identified differentially expressed genes associated with aspirin use, adjusted for birth decade and cohort. False discovery rates (FDR) were used to account for multiple testing and gene set enrichment analysis was used to identify biological pathways. Results No individual genes were significantly differentially expressed in ovarian tumors in low or regular‐dose aspirin users accounting for multiple comparisons. However, current versus never use of low‐dose aspirin was associated with upregulation of immune pathways (e.g., allograft rejection, FDR = 5.8 × 10−10; interferon‐gamma response, FDR = 2.0 × 10−4) and downregulation of estrogen response pathways (e.g., estrogen response late, FDR = 4.9 × 10−8). Ovarian tumors from current regular aspirin users versus never users were also associated with upregulation in interferon pathways (FDR
Document Type: article in journal/newspaper
Language: English
Relation: https://doi.org/10.1002/cam4.6386; https://doaj.org/toc/2045-7634; https://doaj.org/article/4e60807f476e4be1828c4fc2a22e7d83
DOI: 10.1002/cam4.6386
Availability: https://doi.org/10.1002/cam4.6386; https://doaj.org/article/4e60807f476e4be1828c4fc2a22e7d83
Accession Number: edsbas.3CAD53E7
Database: BASE